Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda

Vaccine

Volumn 25, Issue 39-40, 2007, Pages 7001-7005

  Muganga, Narcisse ^b   Uwimana, Jeannine ^b   Fidele, Ngabo ^a   Gahimbare, Laetitia ^b   Gessner, Bradford D ^c   Mueller, Judith E ^c   Mhlanga, Bekithemba R ^d   Katsande, Reggis ^d   Herbinger, Karl Heinz ^c   Rugambwa, Celse ^d  

^a Ministry of Health   (Rwanda)

^b Centre Hospitalier Universitaire de Kigali   (Rwanda)

^c INSTITUT PASTEUR   (France)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Epidemiology; Haemophilus influenzae; Meningitis; Rwanda; Vaccine; Vaccine effectiveness; Vaccine impact

Indexed keywords

ANTIRETROVIRUS AGENT; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIPHTHERIA; DRUG EFFICACY; HOSPITAL; HUMAN; INFANT; MAJOR CLINICAL STUDY; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RWANDA; TETANUS;

CHILD, PRESCHOOL; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INFANT; MENINGITIS, HAEMOPHILUS; POLYSACCHARIDES, BACTERIAL; POPULATION SURVEILLANCE; RWANDA; TREATMENT OUTCOME; VACCINES, CONJUGATE;

EID: 34548550433     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.06.032     Document Type: Article

References (23)

1. World Health Organization (WHO). Haemophilus influenzae type b (Hib) meningitis in the pre-vaccine era: a global review of incidence, age distributions, and case-fatality rates. Department of Vaccines and Biologicals, World Health Organization. WHO/V&B/02.18, 2002.
2. Gessner B.D. Worldwide variation in Haemophilus influenzae type b meningitis incidence and its association with ampicillin resistance. Eur J Clin Microbiol Infect Dis 21 (2002) 79-87
3. Cadoz M., Denis F., and Mar I.D. Etude épidémiologique des cas de méningites purulentes hospitalisés à Dakar pendant la décennie 1970-1979. Bull World Health Organ 59 (1981) 575-584
4. Bijlmer H.A., and van Alphen L. A prospective, population-based study of Haemophilus influenzae type b meningitis in The Gambia and the possible consequences. J Infect Dis 165 Suppl 1 (1992) S29-S32
5. Adegbola R.A., Mulholland E.K., Falade A.G., Secka O., Sarge-Njai R., Corrah T., et al. Haemophilus influenzae type b disease in the western region of The Gambia: background surveillance for a vaccine efficacy trial. Ann Trop Paediatr 16 (1996) 103-111
6. Campagne G., Schuchat A., Djibo S., Ousseini A., Cisse L., and Chippaux J.P. Epidemiology of bacterial meningitis in Niamey, Niger, 1981-1996. Bull World Health Organ 77 (1999) 499-507
7. Hussey G., Hitchcock J., Schaaf H., Coetzee G., Hanslo D., van Schalkwyk E., et al. Epidemiology of invasive Haemophilus influenzae infections in Cape Town, South Africa. Ann Trop Paediatr 14 (1994) 97-103
8. Parent du Chatelet I., Traore Y., Gessner B.D., Antignac A., Naccro B., Njanpop-Lafourcade B.M., et al. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clin Infect Dis 40 (2005) 17-25
9. Sow S.O., Diallo S., Campbell J.D., Tapia M.D., Keita T., Keita M.M., et al. Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine. Pediatr Infect Dis J 24 (2005) 533-537
10. Mulholland K., Hilton S., Adegbola R., Usen S., Oparaugo A., Omosigho C., et al. Randomized trial of Haemophilus influenzae type b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants. Lancet 349 (1997) 1191-1197
11. Adegbola R.A., Secka O., Lahai G., Lloyd-Evans N., Njie A., Usen S., et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunization with a Hib conjugate vaccine: a prospective study. Lancet 366 (2005) 144-150
12. Daza P., Banda R., Misoya K., Katsulukuta A., Gessner B.D., Katsande R., et al. The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence. Vaccine 24 (2006) 6232-6239
13. Cogwill K.D., Ndiritu M., Nyiro J., Slack M.P., Chiphatsi S., Ismail A., et al. Effectiveness of Haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA 296 (2006) 671-678
14. Regional Office for Africa, World Health Organization, WHO/AFRO. Website: http://afro.who.int/hib/index.html; 2007 [last accessed March 16, 2007].
15. World Bank. Website: http://web.worldbank.org/WBSITE/EXTERNAL/COUNTRIES/AFRICAEXT/RWANDAEXTN/0,menuPK:368741∼pagePK:141132∼piPK:141109∼theSitePK:368651,00.html, 2007 [last accessed March 16, 2007].
16. Regional Office for Africa, World Health Organization (WHO/AFRO). Website: http://www.afro.who.int/home/countries/fact_sheets/rwanda.pdf, 2007 [last accessed March 16, 2007].
17. World Health Organization, WHO. Website: http://www.who.int/hiv/HIVCP_RWA.pdf, 2007 [last accessed March 16, 2007].
18. Salaun-Saraux P., Saraux A., Lepage P., Van Goethem C., Hitimana D.G., Bazubagira A., et al. Septic meningitis in children in Rwanda from 1983 to 1990. Retrospective study at the Kigali Hospital Center. Med Trop (Mars) 55 (1995) 41-45
19. World Health Organization, WHO. Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. WHO Communicable disease surveillance and response. WHO/CDS/CSR/EDC/99.7, 1999.
20. World Health Organization. Generic protocol for population-based surveillance of Haemophilus influenzae type b. Global Programme for Vaccines and Immunizations, Vaccine Research and Development. WHO/VRD/GEN/95.05, 1996.
21. Shapiro E.D. Case-control studies of the effectiveness of vaccines: validity and assessment of potential bias. Pediatr Infect Dis J 23 (2004) 127-131
22. Adegbola R.A., Secka O., Lahai G., Lloyd-Evans N., Njie A., Usen S., et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 366 (2005) 144-150
23. Moulton L.H., Chung S.E., Croll J., Reid R., Weatherholtz R.C., and Santosham M. Estimation of the indirect effect of Haemophilus influenzae type b vaccine in an American Indian population. Int J Epidemiol 29 (2000) 753-756